StocksMedium•4 November 2026•
1 min read
Aurobindo Pharma Q2 Profit Jumps 33% as Company Declares Interim Dividend
Key Facts
1Aurobindo Pharma's net profit rose 33% to Rs 1,126 crore in the second quarter of fiscal 2026.
2Revenue grew 24% to Rs 10,263 crore, while EBITDA rose 28.5% to Rs 2,156 crore.
3The company declared an interim dividend of Rs 7 per share, to be disbursed by Nov. 20, 2026.
Aurobindo Pharma's net profit rose 33% to Rs 1,126 crore in the second quarter of fiscal 2026. NDTV Profit reported that the company's revenue grew 24% to Rs 10,263 crore, while EBITDA climbed 28.5% to reach Rs 2,156 crore.
The company declared an interim dividend of Rs 7 per share, with disbursement to eligible shareholders scheduled by November 20, 2026. Operational efficiency improved during the period as the EBITDA margin widened to 21% from 20.3% in the year-ago quarter.
Latest Updates · 1
- Notable·
Update: Aurobindo Pharma attributed its quarterly profit growth to strong demand in the United States market. This performance in the US market supported the company's overall revenue increase to Rs 10,263 crore during the second quarter.